Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Jul 16;361(3):255-63.
doi: 10.1056/NEJMoa0809437.

Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect

Affiliations

Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect

Richard J Caselli et al. N Engl J Med. .

Abstract

Background: The APOE epsilon4 allele is associated with the risk of late-onset Alzheimer's disease. The age at which memory decline diverges among persons who are homozygous for the APOE epsilon4 allele, those who are heterozygous for the allele, and noncarriers is unknown.

Methods: Using local advertisements, we recruited cognitively normal subjects between the ages of 21 and 97 years, who were grouped according to their APOE epsilon4 status. We then followed the subjects with longitudinal neuropsychological testing. Anyone in whom mild cognitive impairment or dementia developed during follow-up was excluded. We compared the rates of decline in predetermined cognitive measures between carriers and noncarriers of the APOE epsilon4 allele, using a mixed model for longitudinal change with age.

Results: We analyzed 815 subjects: 317 APOE epsilon4 carriers (79 who were homozygous for the APOE epsilon4 allele and 238 who were heterozygous) and 498 noncarriers. Carriers, as compared with noncarriers, were generally younger (mean age, 58.0 vs. 61.4 years; P<0.001) and were followed for a longer period (5.3 vs. 4.7 years, P=0.01), with an equivalent duration of formal education (15.4 years) and proportion of women (69%). Longitudinal decline in memory in carriers began before the age of 60 years and showed greater acceleration than in noncarriers (P=0.03), with a possible allele-dose effect (P=0.008). We observed similar although weaker effects on measures of visuospatial awareness and general mental status.

Conclusions: Age-related memory decline in APOE epsilon4 carriers diverges from that of noncarriers before the age of 60 years, despite ongoing normal clinical status.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Mean cross-sectional (1) and longitudinal trajectories (2) of the AVLT-LTM (A), MMSE (B), COWAT (C), and JLO (D) by ApoE e4 carrier status (noncarrier vs carrier) based on the mixed model (Table 2). Cross-sectional means represent population mean values at the first examination. APOE e4 noncarriers (solid black line) and carriers (dotted red line). Longitudinal mean trajectories are population mean trajectories for the ages at the first and followup examinations observed in the sample. Predicted values at the first examination and predicted trajectories for each subject in the sample (not shown) are vertically shifted from the displayed means via the random intercept term. APOE e4 noncarriers (black lines) and carriers (red lines).
Figure 2
Figure 2
Mean cross-sectional (1) and longitudinal trajectories (2) of the AVLT-LTM (A), MMSE (B), COWAT (C), and JLO (D) by ApoE e4 genotype (noncarrier vs heterozygotes vs homozygotes) based on the mixed model (Table 3). Cross-sectional means represent population mean values at the first examination. ApoE e4 noncarriers (solid black line), heterozygotes (dotted red line), and homozygotes (dashed blue line). Longitudinal mean trajectories are population mean trajectories for the ages at the first and followup examinations observed in the sample. Predicted values at the first examination and predicted trajectories for each subject in the sample (not shown) are vertically shifted from the displayed means via the random intercept term. APOE e4 noncarriers (black lines), heterozygotes (red lines), and homozygotes (blue lines).

Comment in

References

    1. West RL. An application of prefrontal cortex function theory to cognitive aging. Psychol Bull. 1996;120:272–292. - PubMed
    1. Verhaeghen P, Cerella J. Aging, executive control, and attention: a review of meta-analyses. Neurosci Behav Rev. 2002;26:849–857. - PubMed
    1. Treitz FH, Heyder K, Daum I. Differential course of executive control changes during normal aging. Aging, Neuropsychology, and Cognition. 2007;14:370–393. - PubMed
    1. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol. 1999;56:303–308. - PubMed
    1. Morris JC, Storandt M, Miller JP, McKeel DW, Price JL, Rubin EH, Bell L. Mild cognitive impairment represents early stage Alzheimer disease. Arch Neurol. 2001;58:397–405. - PubMed

Publication types

Substances